 NEW YORK--BUSINESS WIRE--WaterMill Asset Management Corp. together with its affiliates, WaterMill or we today announced that Glass, Lewis Co., LLC Glass Lewis, a leading proxy advisory firm, has endorsed its case for meaningful change at Ziopharm Oncology, Inc. NASDAQ: ZIOP Ziopharm or the Company and recommended shareholders vote for all five proposals on WaterMills WHITE consent card. In particular, Glass Lewis supports the addition of the entire WaterMill slate R 